Leading Cancer Drugmaker BeiGene Reports First Quarterly GAAP Profit in Q1 2025 Driven by Surging Brukinsa Sales
Leading Cancer Drugmaker BeiGene Reports First Quarterly GAAP Profit in Q1 2025 Driven by Surging Brukinsa Sales